Tzogani, K., Penttilä, K., Lähteenvuo, J., Lapveteläinen, T., Lopez Anglada, L., Prieto, C., . . . Pignatti, F. (2020). EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma. Oncologist.
Chicago Style aipamenaTzogani, Kyriaki, et al. "EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients With Relapsed/Refractory Multiple Myeloma." Oncologist 2020.
MLA aipamenaTzogani, Kyriaki, et al. "EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients With Relapsed/Refractory Multiple Myeloma." Oncologist 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.